270 related articles for article (PubMed ID: 9169820)
1. An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma.
Murata R; Nishimura Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1107-13. PubMed ID: 9169820
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.
Teicher BA; Holden SA; Dupuis NP; Kakeji Y; Ikebe M; Emi Y; Goff D
Breast Cancer Res Treat; 1995; 36(2):227-36. PubMed ID: 8534870
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia.
Nishimura Y; Murata R; Hiraoka M
Br J Cancer; 1996 Feb; 73(3):270-4. PubMed ID: 8562329
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.
Takei H; Lee ES; Cisneros A; Jordan VC
Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127
[TBL] [Abstract][Full Text] [Related]
5. The effect of hyperthermia on reoxygenation during the fractionated radiotherapy of two murine tumors, FSa-II and MCa.
Nishimura Y; Urano M
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):141-8. PubMed ID: 8175421
[TBL] [Abstract][Full Text] [Related]
6. Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma.
Kuroda M; Urano M; Nishimura Y; Reynolds R
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):411-7. PubMed ID: 9226330
[TBL] [Abstract][Full Text] [Related]
7. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
[TBL] [Abstract][Full Text] [Related]
10. Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma.
Morita T; Shinohara N; Tokue A
Br J Urol; 1994 Oct; 74(4):416-21. PubMed ID: 7529632
[TBL] [Abstract][Full Text] [Related]
11. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
Kato T; Sato K; Kakinuma H; Matsuda Y
Cancer Res; 1994 Oct; 54(19):5143-7. PubMed ID: 7522956
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of TNP-470 is not associated to decrease of angiogenesis in an experimental malignant neuroectodermic tumor.
Morales C; Zurita M; Vaquero J
J Neurooncol; 2002 Jun; 58(2):131-6. PubMed ID: 12164684
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of angiogenesis inhibitor 0-(chloroacetyl-carbamoyl) fumagillol (TNP-470) against murine renal cell carcinoma.
Fujioka T; Hasegawa M; Ogiu K; Matsushita Y; Sato M; Kubo T
J Urol; 1996 May; 155(5):1775-8. PubMed ID: 8627882
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470.
Shishido T; Yasoshima T; Denno R; Sato N; Hirata K
Jpn J Cancer Res; 1996 Sep; 87(9):958-62. PubMed ID: 8878459
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N
Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218
[TBL] [Abstract][Full Text] [Related]
16. TNP-470 promotes initial vascular sprouting in xenograft tumors.
Huang J; Frischer JS; New T; Kim ES; Serur A; Lee A; Kadenhe-Chiwishe A; Pollyea DA; Yokoi A; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Mol Cancer Ther; 2004 Mar; 3(3):335-43. PubMed ID: 15026554
[TBL] [Abstract][Full Text] [Related]
17. Changes in tumor vascularization after irradiation, anthracyclin, or antiangiogenic treatment in nitrosomethyl ureas-induced rat mammary tumors.
Denis F; Colas S; Chami L; Louisot P; Le Floch O; Tranquart F; Bougnoux P
Clin Cancer Res; 2003 Oct; 9(12):4546-52. PubMed ID: 14555529
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2.
Mori S; Yoshikawa H; Hashimoto J; Ueda T; Funai H; Kato M; Takaoka K
Bone; 1998 Feb; 22(2):99-105. PubMed ID: 9477232
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma.
Xia JL; Yang BH; Tang ZY; Sun FX; Xue Q; Gao DM
J Cancer Res Clin Oncol; 1997; 123(7):383-7. PubMed ID: 9260590
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo.
Singh Y; Shikata N; Kiyozuka Y; Nambu H; Morimoto J; Kurebayashi J; Hioki K; Tsubura A
Breast Cancer Res Treat; 1997 Aug; 45(1):15-27. PubMed ID: 9285113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
